Tirzepatide

Drugs used in diabetes | Endocrine System

Items (National)
1.3M
NHS Cost
£137.2M
Practices
6,596
Avg per Practice
194

Overview

Tirzepatide is prescribed by 6,596 GP practices across England. In the last 12 months, 1,281,066 items were prescribed at a total cost of £137,219,837 to the NHS. It is classified under BNF Chapter Endocrine System, Section Drugs used in diabetes.

Monthly Prescribing Trend

Jun 2026
25,670
Jun 2026
39,541
Jun 2026
59,418
Jun 2026
71,445
Jun 2026
82,818
Jun 2026
103,838
Jun 2026
112,764
Jun 2026
124,864
Jun 2026
141,946
Jun 2026
139,740
Jun 2026
162,215
Jun 2026
174,899

Prescribing by Area

AreaItemsPracticesAvg/Practicevs National
B 59.2K 255 232 +19.6% ▲
LE 50.3K 123 409 +110.7% ▲
DN 31.2K 88 354 +82.3% ▲
M 30.3K 171 177 -8.8% ▼
PL 28.6K 49 585 +201.0% ▲
PO 27.9K 62 451 +132.0% ▲
NN 26.3K 66 399 +105.5% ▲
BS 26.2K 80 328 +68.7% ▲
S 25.7K 165 156 -19.7% ▼
BN 24.8K 75 331 +70.3% ▲
PE 23.2K 88 264 +35.9% ▲
NG 21.9K 121 181 -6.8% ▼
ME 21.4K 68 315 +61.9% ▲
SN 21.4K 48 445 +129.4% ▲
RG 20.9K 66 316 +62.7% ▲
GU 20.4K 65 314 +61.4% ▲
E 20.3K 135 151 -22.5% ▼
SS 20.0K 72 278 +43.0% ▲
WF 19.0K 59 323 +66.1% ▲
CH 18.6K 66 282 +45.3% ▲

BNF Classification

Related drugs in this section

Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.